Guardian Pharmacy Services, Inc. (GRDN)
(Delayed Data from NYSE)
$20.76 USD
+0.50 (2.47%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $20.70 -0.06 (-0.29%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth F Momentum C VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
GRDN 20.76 +0.50(2.47%)
Will GRDN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GRDN based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for GRDN
Guardian Pharmacy Services Inc Expands into Oregon with Strategic Acquisition | GRDN stock news
Guardian Pharmacy Services Strengthens Pacific Northwest Presence with Acquisition of ...
BlackRock, Inc. Increases Stake in Guardian Pharmacy Services Inc.
Aristotle Small Cap Equity Q2 2025 Commentary
Guardian Pharmacy Services Inc (GRDN) Announces Q2 2025 Earnings Release and Conference Call | ...